Key result
Inhibition of PAI-1 using catalytic DNA enzymes enhanced bone marrow-dependent neovascularization, cardiomyocyte regeneration, and functional cardiac recovery after myocardial infarction.
Why the study?
Does down-regulation of PAI-1 expression improve myocardial neovascularization and functional recovery in a rat model of myocardial infarction?
Does down-regulation of PAI-1 expression improve myocardial neovascularization and functional recovery in a rat model of myocardial infarction?
Answers are grounded in this paper and cite their sources.
Down-regulation of PAI-1 expression enhances bone marrow-dependent neovascularization and functional recovery after myocardial infarction in a preclinical model.
Human adult bone marrow-derived endothelial progenitors, or angioblasts, induce neovascularization of infarcted myocardium via mechanisms involving both cell surface urokinase-type plasminogen activator, and interactions between beta integrins and tissue vitronectin. Because each of these processes is regulated by plasminogen activator inhibitor (PAI)-1, we selectively down-regulated PAI-1 mRNA in the adult heart to examine the effects on postinfarct neovascularization and myocardial function. Sequence-specific catalytic DNA enzymes inhibited rat PAI-1 mRNA and protein expression in peri-infarct endothelium within 48 h of administration, and maintained down-regulation for at least 2 wk. PAI-1 inhibition enhanced vitronectin-dependent transendothelial migration of human bone marrow-derived CD34+ cells, and resulted in a striking augmentation of angioblast-dependent neovascularization. Development of large, thin-walled vessels at the peri-infarct region was accompanied by induction of proliferation and regeneration of endogenous cardiomyocytes and functional cardiac recovery. These results identify a causal relationship between elevated PAI-1 levels and poor outcome in patients with myocardial infarction through mechanisms that directly inhibit bone marrow-dependent neovascularization. Strategies that reduce myocardial PAI-1 expression appear capable of enhancing cardiac neovascularization, regeneration, and functional recovery after ischemic insult.
No takes yet. Share an insight, caveat, or question.
Xiang et al. (2004) studied Myocardial infarction. Sequence-specific catalytic DNA enzymes targeting PAI-1 mRNA was evaluated on Postinfarct neovascularization and myocardial function. Inhibition of PAI-1 using catalytic DNA enzymes enhanced bone marrow-dependent neovascularization, cardiomyocyte regeneration, and functional cardiac recovery after myocardial infarction.
Synapse has enriched 10 related papers. Consider them for comparative context: